How to buy Teva Pharmaceutical Industries (TEVA) shares in the UK

Learn how to easily invest in Teva Pharmaceutical Industries shares.

Teva Pharma Industries Ltd ADR (TEVA) is a publicly traded drug manufacturers-specialty and generic business based in the US. In the week up to 4 October Teva Pharmaceutical Industries shares surged 14.08% to a closing position of $8.83. However, over the last 12 months, Teva Pharmaceutical Industries's share price has fallen by 4.42% from $9.73. Teva Pharmaceutical Industries is listed on the NYSE and employs 34,713 staff. All prices are listed in US Dollars.

How to buy shares in Teva Pharmaceutical Industries

  1. Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
  2. Open your account. You'll need your ID, bank details and national insurance number.
  3. Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
  4. Search the platform for stock code: TEVA in this case.
  5. Research Teva Pharmaceutical Industries shares. The platform should provide the latest information available.
  6. Buy your Teva Pharmaceutical Industries shares. It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.

Fees for buying 100x Teva Pharmaceutical Industries shares with popular platforms

Both exchange rates and share prices fluctuate in real time, so the costs presented here should be considered as a guide only. They do not incorporate stamp duty. Always refer to the platform itself for availability and pricing – which may differ from our information.

Platform Platform fee Min. initial deposit Trading fee estimate
eToro Free Stocks logo £0 $10 £4.10
£825.02 total
Capital at risk
IG Share Dealing logo £0 £250 £12.98
£833.89 total
Capital at risk
Fineco logo £0 No minimum £8.21
£829.12 total
Capital at risk
Hargreaves Lansdown Fund and Share Account logo £0 £1 £20.16
£841.07 total
Capital at risk
Degiro Share Dealing logo £0 £0.01 £0.82
£821.73 total
Capital at risk
interactive investor Trading Account logo £9.99 per month No minimum £20.30
£841.21 total
Capital at risk
Stake logo £0 £50 £4.10
£825.02 total
Capital at risk
Halifax Share Dealing Account logo £36 per year £20 £19.76
£840.67 total
Capital at risk

Full comparison of share dealing platforms

Teva Pharmaceutical Industries share price (NYSE:TEVA)

Use our graph to track the performance of TEVA stocks over time.

Teva Pharmaceutical Industries price performance over time

Historical closes compared with the last close of $9.3

1 week (2022-09-28) 16.83%
1 month (2022-09-02) 5.20%
3 months (2022-07-05) 20.62%
1 year (2021-10-05) -4.42%
2 years (2020-10-05) 9.3
3 years (2019-10-04) 33.43%
5 years (2017-10-05) -40.69%

Is it a good time to buy Teva Pharmaceutical Industries stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page.

Promoted
eToro Free Stocks

Invest in Teva Pharmaceutical Industries shares with 0% commission

  • Start investing from as little as $10
  • Pay no stamp duty on UK shares
  • Join 25 million users who trust their investments with eToro
Other fees apply. Capital at risk

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

Is Teva Pharmaceutical Industries under- or over-valued?

Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value.

PEG ratio

Teva Pharmaceutical Industries's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.755. A PEG ratio below 1 can be interpreted as meaning the shares are not overvalued given the current rate of growth.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Teva Pharmaceutical Industries's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

EBITDA

Teva Pharmaceutical Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is a whopping $4.2 billion (£3.7 billion).

The EBITDA is a measure of a Teva Pharmaceutical Industries's overall financial performance and is widely used to measure a its profitability.

Environmental, social and governance track record

Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Teva Pharmaceutical Industries.

Total ESG risk score

Teva Pharmaceutical Industries's total ESG risk: 58.8

Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Teva Pharmaceutical Industries's overall score of 58.8 (as at 01/01/2019) is pretty weak – landing it in it in the 76th percentile of companies rated in the same sector.

ESG scores are increasingly used to estimate the level of risk a company like Teva Pharmaceutical Industries is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).

Environmental score

Teva Pharmaceutical Industries's environmental score: 77.02/100

Teva Pharmaceutical Industries's environmental score of 77.02 puts it squarely in the 87th percentile of companies rated in the same sector. This could suggest that Teva Pharmaceutical Industries is a laggard in its sector in terms of its environmental impact, and exposed to a greater level of risk.

Social score

Teva Pharmaceutical Industries's social score: 47.2/100

Teva Pharmaceutical Industries's social score of 47.2 puts it squarely in the 58th percentile of companies rated in the same sector. This could suggest that Teva Pharmaceutical Industries is pretty average in terms of looking after its workforce and social impact.

Governance score

Teva Pharmaceutical Industries's governance score: 65.26/100

Teva Pharmaceutical Industries's governance score puts it squarely in the 81st percentile of companies rated in the same sector. That could suggest that Teva Pharmaceutical Industries is a laggard in its sector in terms of responsible leadership, and exposed to a greater level of risk.

Controversy score

Teva Pharmaceutical Industries's controversy score: 3/5

ESG scores also evaluate any incidences of controversy that a company has been involved in. A high-profile company, Teva Pharmaceutical Industries scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Teva Pharmaceutical Industries hasn't always managed to keep its nose clean.

Environmental, social, and governance (ESG) summary

Teva Pharma Industries Ltd ADR was last rated for ESG on: 2019-01-01.

Total ESG score 58.8
Total ESG percentile 76.26
Environmental score 77.02
Environmental score percentile 87.16
Social score 47.2
Social score percentile 58.24
Governance score 65.26
Governance score percentile 80.64
Level of controversy 3

Teva Pharmaceutical Industries shares at a glance

Information last updated 2021-07-09.
Open$9.26
High$9.38
Low$9.22
Close$9.3
Previous close$9.14
Change$0.16
Change %1.7505%
Volume7,427,562
Information last updated 2022-10-02.
52-week range$6.7791 - $11.34
50-day moving average$9.283
200-day moving average$8.6132
Wall St. target price$10.5
Dividend yield$0 (0%)
Earnings per share (TTM)$-0.557

Do Teva Pharmaceutical Industries shares pay dividends?

We're not expecting Teva Pharmaceutical Industries to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.

Share price volatility

Over the last 12 months, Teva Pharmaceutical Industries's shares have ranged in value from as little as $6.7791 up to $11.34. A popular way to gauge a stock's volatility is its "beta".

TEVA.US volatility(beta: 1.27)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Teva Pharmaceutical Industries's is 1.2693. This would suggest that Teva Pharmaceutical Industries's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Shares similar to Teva Pharmaceutical Industries

Frequently asked questions

All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site